1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
The cannabinoid receptor 2 (CB2 receptor) has attracted considerable interest, mainly due to its potential as a target for therapeutics for treating various diseases that have a neuroinflammatory or neurodegenerative component while avoiding the adverse psychotropic effects that accompany CB1 recept...
Saved in:
Main Authors: | Amer H. Tarawneh, Pankaj Pandey, Lo'ay A. Al-Momani, Anastassiya V. Gadetskaya, Sultan T. Abu-Orabi, Robert J. Doerksen, Stephen J. Cutler |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/e155f8c981fa43f99cbbbced5bbfc653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations
by: Sang Won Jung, et al.
Published: (2018) -
Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice
by: Jin Cong, et al.
Published: (2021) -
Localization of Cannabinoid Receptor 1 (CB1) in Submandibular and Sublingual Salivary Glands of Mice throughout Postnatal Development
by: Hipkaeo,Wiphawi, et al.
Published: (2015) -
The Vertical and Horizontal Pathways in the Monkey Retina Are Modulated by Typical and Atypical Cannabinoid Receptors
by: Joseph Bouskila, et al.
Published: (2021) -
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
by: Francisco Navarrete, et al.
Published: (2021)